Cannabidiol for people with schizophrenia

Diana Buitrago-Garcia, Guillermo Sánchez Vanegas, Paula Alejandra Sánchez Correa, Stela del pilar Baracaldo, Santiago Felipe Gallego Gallego, Lone Baandrup

Research output: Contribution to journalArticlepeer-review


Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of CBD in the treatment of people with schizophrenia.

Original languageEnglish
Article numberCD014602
Pages (from-to)1-15
Number of pages15
JournalCochrane Database of Systematic Reviews
Issue number11
StatePublished - 16 Nov 2022


  • Cannabidiol
  • Schizophrenia
  • Protocol


Dive into the research topics of 'Cannabidiol for people with schizophrenia'. Together they form a unique fingerprint.

Cite this